Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines-Reference-Cited by-同舟云学术

Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines

Published:2020-03-03 Issue:3 Volume:19 Page:235-246
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Lei Xinnuo¹²^ORCID,Cai Xiong³,Yang Yi¹²^ORCID

Affiliation:

1. Provincial Key Laboratory of Protein Engineering in Animal Vaccines, Research Center of Reverse Vaccinology (RCRV), Hunan Agricultural University, Changsha, Hunan, China

2. Laboratory of Functional Proteomics (LFP), College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China

3. Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2020.1738227

Reference130 articles.

1. Bioengineering virus-like particles as vaccines

2. Virus-like particles as immunogens

3. Use of plant viruses and virus-like particles for the creation of novel vaccines

4. Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

5. Enveloped virus-like particles as vaccines against pathogenic arboviruses

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermolecular disulfide bond of PRRSV GP5 and M facilitates VLPs secretion and cell binding;Veterinary Microbiology;2024-11

2. Experimental and molecular dynamics simulation studies on the physical properties of three HBc-VLP derivatives as nanoparticle protein vaccine candidates;Vaccine;2024-09

3. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches;Journal of Medical Virology;2024-09

4. Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2;Frontiers in Immunology;2024-07-26

5. Toward innovative veterinary nanoparticle vaccines;Animal Diseases;2024-05-10